Research Articles | Page 74 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Myelodysplastic syndromes in the United States: an update for clinicians Apr 2014 Ann Med. myelodysplastic syndromes (MDS)
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data Jan 2015 Ann Lab Med paroxysmal nocturnal hemoglobinuria (PNH)
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Apr 2012 Ann Hematol. aplastic anemia
Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia Dec 2014 Ann Hematol aplastic anemia
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated? Jul 2012 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function Apr 2014 Ann Hematol myelodysplastic syndromes (MDS)
Efficacy and safety of deferasirox in myelodysplastic syndromes Feb 2013 Ann Hematol myelodysplastic syndromes (MDS)
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. May 2013 Ann Hematol myelodysplastic syndromes (MDS)
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients Jul 2013 Ann Hematol myelodysplastic syndromes (MDS)
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability. May 2013 Ann Hematol myelodysplastic syndromes (MDS)